News

06.11.2007 Immunoassays To Reap Benefits of New Technologies

The immunoassay assay is undergoing a major makeover. New amplification methods offer the promise to peer deeper into the proteome; new detection methods offer the promise to see clearer; new multiplexing to look faster and more efficiently; and new content to observe farther. These new technologies are addressing significant unmet needs in sensitivity, accuracy, speed, cost and breadth, according to a new report from BioPerspectives and Bachmann Consulting.

The new report, “Next-Generation Immunoassays: A Market and Technical Analysis of Research Applications,” details the opportunities and challenges in a market valued at more than $1.1 billion in 2003 and projected to grow to more than $2.2 billion in 2012. The report is based on surveys of researchers and thorough evaluations of more than 70 technologies encompassing novel antibody generation, real-time detection, new amplification methods and multiplexed antibody arrays. The financial projections are based on a 3 by 5 market matrix model encompassing instruments, antibodies and other reagents and consumables across ELISAs, Western blots, immunoprecipitations, antibody arrays and novel antibody characterization methods.

In addition, the report comes with an hour of discussion (pending availability and limited to a conference call format) with Steven Bodovitz, Principal of BioPerspectives, or Jutta Bachmann, CEO of Bachmann Consulting. For more information, please visit www.bioperspectives.com or www.jbachmann-consulting.com.

« back